Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD‐6972 in healthy subjects and subjects with type 2 diabetes mellitus

AIM: To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of a novel, oral glucagon receptor antagonist, LGD‐6972, in healthy subjects and subjects with type 2 diabetes (T2DM). METHODS: In the single ascending dose study, LGD‐6972 (2‐480 mg) was ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Vajda, Eric G., Logan, Douglas, Lasseter, Kenneth, Armas, Danielle, Plotkin, Diane J., Pipkin, JD, Li, Yong-Xi, Zhou, Rong, Klein, David, Wei, Xiaoxiong, Dilzer, Stacy, Zhi, Lin, Marschke, Keith B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215471/
https://www.ncbi.nlm.nih.gov/pubmed/27501510
http://dx.doi.org/10.1111/dom.12752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215471/
https://www.ncbi.nlm.nih.gov/pubmed/27501510
http://dx.doi.org/10.1111/dom.12752

Ejemplares similares